Archive · 30 Jul 2026
Torrent Pharma Q1 FY27: Profit Up 3%, Revenue Soars 55%
Torrent Pharmaceuticals is a big drug company in India.
In the first quarter of its 2027 financial year, it made a profit of 566 crore rupees, which is a little more than last year.
Its sales jumped 55% to almost 5,000 crore rupees, thanks to good sales in India, Brazil, the U.S., and Germany.
The company also earned more money before taxes, called EBITDA, which grew 61% to 1,664 crore rupees.
A one‑time loss of 21 crore rupees from buying another company, JB Pharma, slowed the profit a bit.
The stock price finished the day flat at 4,872 rupees on the Indian stock market.
Torrent Pharmaceuticals posted Q1 FY27 net profit of Rs 566 crore, up 3% YoY.
Revenue rose 55% YoY to Rs 4,921 crore, driven by India, Brazil, US, and Germany sales.
EBITDA increased 61% YoY to Rs 1,664 crore, margin improved to 33.8%.
One‑time loss of Rs 21 crore from acquisition costs of JB Pharma weighed on growth.
Share price closed flat at Rs 4,872.10 on NSE, up 5% in the last month and 24% in six months.
- Who
- Torrent Pharmaceuticals
- What
- Q1 FY27 financial results
- When
- April–June 2026
- Where
- India, Brazil, United States, Germany
- Why
- To report earnings and growth performance
- Net profit
- Rs 566 crore
- Revenue
- Rs 4,921 crore
- EBITDA
- Rs 1,664 crore
- One‑time loss
- Rs 21 crore
- Share price (NSE)
- Rs 4,872.10